Evidence map›Paper›PMID 31645127›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2019

Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated With Coronary Artery Disease.

Trent D Evans, Xiangyu Zhang, Reece E Clark, Arturo Alisio, Eric Song, Hanrui Zhang, Muredach P Reilly, Nathan O Stitziel, Babak Razani

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Oxidized LDL Induces Pro-Inflammatory Transcriptomic and Epigenomic Responses in Human CD4FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  9. Article
  10. Pathogenic signal peptide variants in the human genome.NAR genomics and bioinformatics · 2023
    Article
  11. Recent insights into lysosomal acid lipase deficiency.Trends in molecular medicine · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Trent D EvansFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Xiangyu ZhangFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Reece E ClarkFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Arturo AlisioFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Eric SongFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Hanrui ZhangDepartment of Medicine, Cardiology Division, Columbia University Medical Center, New York (H.Z., M.P.R.).
Muredach P ReillyDepartment of Medicine, Cardiology Division, Columbia University Medical Center, New York (H.Z., M.P.R.).
Nathan O StitzielFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Babak RazaniFrom the Cardiovascular Division, Department of Medicine (T.D.E., X.Z., R.E.C., A.A., E.S., N.O.S., B.R.), Washington University in St. Louis School of Medicine, MO.
Washington University in St. Louis · USColumbia University Irving Medical Center · USJohn Cochran VA Medical Center · US

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
Elucidation of Tissue-Specific Transcriptomic Profiles in Cardiometabolic DiseaseR01HL113147 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LI, MINGYAO, REILLY, MUREDACH P · 2012 to 2022
$6.8M
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSISR01HL125838 · NHLBI · WASHINGTON UNIVERSITY · PI RAZANI, BABAK · 2015 to 2025
$4.6M
Human LincRNAs in Macrophage Biology and Related Cardiometabolic DiseasesR01HL132561 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2017 to 2020
$2.8M
Mentored Patient Oriented Research in Cardiometabolic DiseaseK24HL107643 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI REILLY, MUREDACH P · 2011 to 2020
$1.4M
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosisR00HL130574 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, HANRUI · 2018 to 2020
$733k
Characterization of a Lysosomal Acid Lipase Variant Associated with Coronary DiseaseF31HL132434 · NHLBI · WASHINGTON UNIVERSITY · PI EVANS, TRENT · 2016 to 2019
$114k
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat AtherosclerosisI01BX003415 · VA · VETERANS HEALTH ADMINISTRATION · PI RAZANI, BABAK · 2018 to 2025
–
BLRD VA I01 BX003415NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002345NHLBI NIH HHS F31 HL132434NHLBI NIH HHS K24 HL107643NHLBI NIH HHS R00 HL130574NHLBI NIH HHS R01 HL113147NHLBI NIH HHS R01 HL125838NHLBI NIH HHS R01 HL132561NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

objectiveLIPA (lysosomal acid lipase) mediates cholesteryl ester hydrolysis, and patients with rare loss-of-function mutations develop hypercholesterolemia and severe disease. Genome-wide association studies of coronary artery disease have identified several tightly linked, common intronic risk variants in

conclusionsOur findings show that common LIPA exonic variants in the signal peptide are of minimal functional significance and suggest coronary artery disease risk is instead associated with increased LIPA function linked to intronic variants. Understanding the mechanisms and cell-specific contexts of LIPA function in the plaque is necessary to understand its association with cardiovascular risk.

Indexed as

MutationAdultCoronary Artery DiseaseDNADNA Mutational AnalysisFemaleGenome-Wide Association StudyHumansMaleMiddle AgedMonocytesPhenotypeSterol EsteraseYoung AdultDNALIPA protein, humanSterol Esteraseatherosclerosiscoronary artery diseasehuman geneticsmonocytesrisk

Identifiers

PMID31645127
PMCPMC7050600
OpenAlexW2981637869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.